U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Grants > Search Current & Recent Grants > Impact of antiretroviral therapy on liver fibrosis in Zambian HIV/HBV patients Print

COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

Impact of antiretroviral therapy on liver fibrosis in Zambian HIV/HBV patients

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

International Research Scientist Development Award (IRSDA)

Project Information in NIH RePORTER

Impact of antiretroviral therapy on liver fibrosis in Zambian HIV/HBV patients

Principal Institution

University of North Carolina Chapel Hill

Principal Investigator(s) (PI)

Vinikoor, Michael Jeffrey

Project Contact Information

Email: mjv3@uab.edu

Year(s) Awarded

2015-2018

Collaborating Country

Zambia

Collaborators

Centre for Infectious Disease Research in Zambia (CIDRZ)

Related World Regions / Countries